Linked Data API

Show Search Form

Search Results

1645021
registered interest false more like this
date less than 2023-06-15more like thismore than 2023-06-15
answering body
Department for Levelling Up, Housing and Communities more like this
answering dept id 211 more like this
answering dept short name Levelling Up, Housing and Communities more like this
answering dept sort name Levelling Up, Housing and Communities more like this
hansard heading Department for Levelling Up, Housing and Communities: Disability more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Levelling Up, Housing and Communities, with reference to the National Disability Strategy published on 28 July 2021, which of his Department’s commitments in that strategy that have not been paused as a result of legal action have (a) been fully, (b) been partially and (c) not been implemented. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 189778 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>Please find below a table which sets out which of my department’s commitments in the National Disability Strategy published on 28 July 2021 have been fully and partially implemented. The Department of Levelling Up, Housing and Communities (DLUHC) had no commitments in the Strategy paused as a result of legal action, and no commitments that have not been implemented.</p><p> </p><table><tbody><tr><td><p><strong>DLUHC commitments in the National Disability Strategy (2021)</strong></p></td><td><p><strong>Status of commitment </strong></p></td></tr><tr><td><p>DLUHC [formerly MHCLG] will confirm plans to improve the framework to deliver accessible new homes by December 2021.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] is commissioning new research to develop the statutory guidance on meeting Building Regulations, covering access to and use of buildings (Approved Document M).</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] has commissioned new research to develop robust evidence: - to inform building regulation guidance on the fire safety in new care homes and specialised housing. This will conclude by autumn 2021. - to inform policy in England on the means of escape for disabled people from new buildings. This will conclude by autumn 2021.</p></td><td><p>Partially implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] has committed that 10% of the 180,000 homes built through the £11.5 billion Affordable Homes Programme 2021-26 will be for supported housing.</p></td><td><p>Partially implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] will make the new Shared Ownership model, including the reduced (10%) minimum initial stake, available to disabled people buying a home under the HOLD scheme.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>Following an independent review of the Disabled Facilities Grant published in December 2018, DLUHC [formerly MHCLG] and DHSC will jointly publish new government guidance for local authorities in England on effective delivery of the £573 million Disabled Facilities Grant during 2021.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] will consider how we can support projects that increase high street accessibility for disabled people in the design of any future local growth funding.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] will make £30 million available from summer 2021 to accelerate delivery of Changing Places toilets in existing buildings in England.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>DLUHC [formerly MHCLG] will publish a new National Model Design Code in the summer (2021), setting out design considerations for local planning authorities. The department will use guidance supporting the Code to stress the importance of providing accessible and inclusive play spaces and equipment for all.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>Building on the experience of the Access to Elected Office fund and the EnAble fund, DLUHC [formerly MHCLG] will support a new scheme from April 2022 to support those seeking to become candidates and - as importantly - once they have been elected to public office.</p></td><td><p>Fully implemented</p></td></tr><tr><td><p>The Cabinet Office (now DHLUC for Elections) has introduced the Elections Act which will improve the support provided to voters with disabilities who are voting in polling stations. Returning Officers will have a new responsibility to consider additional support for a range of disabled voters in the polling station. This includes meeting voters’ needs in a more tailored way, and providing equipment and resources that most support voters in their local area. The Act will also remove unnecessary barriers to voting including by widening the pool of people able to provide help to disabled people in casting their vote to any companion who is over the age of 18 in UK Parliamentary elections. The Elections Division also convenes the Access to Elections Working Group which meets with representatives of civil society organisations and charities and the elections sector across the UK to discuss and plan to improve accessibility for all disabled electors.</p></td><td><p>Fully implemented</p></td></tr></tbody></table><p> </p>
answering member constituency Bishop Auckland more like this
answering member printed Dehenna Davison more like this
question first answered
less than 2023-06-20T16:04:32.587Zmore like thismore than 2023-06-20T16:04:32.587Z
answering member
4737
label Biography information for Dehenna Davison more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1645022
registered interest false more like this
date less than 2023-06-15more like thismore than 2023-06-15
answering body
Department for Work and Pensions more like this
answering dept id 29 more like this
answering dept short name Work and Pensions more like this
answering dept sort name Work and Pensions more like this
hansard heading Department for Work and Pensions: Disability more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 25 May 2023 to Question 185576 on Disability, which of his Department’s commitments in the National Disability Strategy that have not been paused as a result of legal action have (a) been fully, (b) been partially and (c) not been implemented. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 189779 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>In January 2022, the High Court declared the National Disability Strategy (NDS) was unlawful because the UK Disability Survey, which informed it, was held to be a voluntary consultation that failed to comply with the legal requirements on public consultations.</p><p>The Department for Work and Pensions (DWP) made five commitments in the NDS:</p><ul><li>Set out proposals to improve the experience of accessing disability benefits;</li><li>Pilot an Access to Work Passport to help disabled people progress through education and move into employment;</li><li>Make available a passport for all young disabled students, including those receiving Disabled Students’ Allowance (DSA), when they leave university;</li><li>Encourage employers to hire disabled people and to create inclusive workplaces by reviewing Disability Confident, strengthening the Voluntary Reporting Framework, and disseminating best practice to employers; and</li><li>Expand trials for supported employment services.</li></ul><p>Since the NDS was published, DWP has:</p><p> </p><ul><li>Published the Health and Disability White Paper, which sets out the Government’s plans to reform the welfare system and make it better meet the needs of disabled people in Great Britain. This includes removing the Work Capability Assessment (meaning claimants will now only have to do one health assessment rather than two) and supporting claimants to try work without fear of losing their financial support;</li><li>Delivered a pilot to test the Adjustments Passport in 3 universities. The pilot results were evaluated by the universities, demonstrating the value of the Adjustments Passport, which as a result is expected to be available, across all nations, beginning in September 2023;</li><li>Implemented a Health Adjustments Passport to support disabled jobseekers and is implementing an Armed Forces Service Leavers Adjustments Passport. The DWP is continuing testing of the Adjustments Passport with various groups, including young people on vocational programmes;</li></ul><ul><li>Paused work directly related to the Disability Confident review and strengthening the Voluntary Reporting Framework. The DWP continues to promote the Disability Confident Scheme and encourage sign-up through our regular engagement with the Business Leaders Group, employers of all sizes and other stakeholders; and</li><li>Provided funding, in partnership with DHSC, for Individual Placement and Support in Primary Care (IPSPC) supported employment services in 12 areas across 41 local authorities in England, to support people with health conditions to access paid jobs, and then support both the individual and their employer to ensure that the job is sustained.</li></ul><p>The Government also announced a wide-reaching package at the Spring Budget to support disabled people, and people with health conditions, to stay in, and return to work. This new investment builds on our existing extensive support to help disabled people and people with health conditions to start, stay and succeed in work.</p><p> </p><p>We remain fully committed to supporting disabled people in the UK through creating more opportunities, protecting their rights and ensuring they fully benefit from, and can contribute to, every aspect of our society. To support this, the DWP will be providing further details of our recent achievements to improve disabled people’s lives in the forthcoming Disability Action Plan consultation due for publication in the summer.</p><p> </p><p>Ahead of this, I as the Minister for Disabled People, Health and Work, will write providing a list of these achievements and will place a copy in the House Library.</p>
answering member constituency Corby more like this
answering member printed Tom Pursglove more like this
question first answered
less than 2023-06-20T15:37:51.7Zmore like thismore than 2023-06-20T15:37:51.7Z
answering member
4369
label Biography information for Tom Pursglove more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643759
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how priority conditions are determined when the Medicines and Healthcare products Regulatory Agency considers applications for licensing of new medicines. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188916 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) does not have a specific list of conditions to which it gives priority when reviewing applications for new medicine licenses. However, it does prioritise applications where there is a public health need, for instance a new medicine which offers a treatment which is not yet available or a generic medicine where there might otherwise be a risk to supply. When deciding whether to prioritise a medicine, the MHRA collaborates with the Department and National Health Service to make sure its decisions align with their priorities.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN
188917 more like this
188918 more like this
189038 more like this
question first answered
less than 2023-06-20T14:52:47.59Zmore like thismore than 2023-06-20T14:52:47.59Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643760
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, which conditions are considered a priority by the Medicines and Healthcare products Regulatory Agency when assessing applications for new licences for medicines. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188917 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) does not have a specific list of conditions to which it gives priority when reviewing applications for new medicine licenses. However, it does prioritise applications where there is a public health need, for instance a new medicine which offers a treatment which is not yet available or a generic medicine where there might otherwise be a risk to supply. When deciding whether to prioritise a medicine, the MHRA collaborates with the Department and National Health Service to make sure its decisions align with their priorities.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN
188916 more like this
188918 more like this
189038 more like this
question first answered
less than 2023-06-20T14:52:47.647Zmore like thismore than 2023-06-20T14:52:47.647Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643762
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency plans next to review the list of priority conditions which determine the speed with which applications for licenses for new medicines are considered. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188918 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) does not have a specific list of conditions to which it gives priority when reviewing applications for new medicine licenses. However, it does prioritise applications where there is a public health need, for instance a new medicine which offers a treatment which is not yet available or a generic medicine where there might otherwise be a risk to supply. When deciding whether to prioritise a medicine, the MHRA collaborates with the Department and National Health Service to make sure its decisions align with their priorities.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN
188916 more like this
188917 more like this
189038 more like this
question first answered
less than 2023-06-20T14:52:47.71Zmore like thismore than 2023-06-20T14:52:47.71Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643763
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to reduce backlogs in D150 applications. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188919 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-21more like thismore than 2023-06-21
answer text <p>Delays to the processing of marketing authorisation applications have resulted from a combination of factors, including implementation of new licensing pathways and the need to divert resource to deal with urgent and unforeseen public health issues like the COVID-19 pandemic. The Medicines and Healthcare products Regulatory Agency (MHRA) is changing its assessment processes to speed up the processing of submitted applications. Resource issues are being addressed as a matter of priority with targeted recruitment. The MHRA is also implementing a new IT system to manage licensing applications and improve processing times.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN 189039 more like this
question first answered
less than 2023-06-21T14:48:30.103Zmore like thismore than 2023-06-21T14:48:30.103Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643764
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, by what date he expects the Medicines and Healthcare products Regulatory Agency to be able to process all D150 submissions within the 150 day timescale. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188920 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-20more like thismore than 2023-06-20
answer text <p>The statutory timelines for processing national applications is 210 days. However, the Medicines and Healthcare products Regulatory Agency (MHRA) is working towards progressing priority applications and good quality submissions within 150 days. To achieve this, the MHRA is proactively engaging with the relevant Trade Associations on how best to improve the quality of marketing authorisation applications, including workshops to support companies. With the measures put in place, the MHRA anticipates that all priority and good quality dossiers that are compliant with legislative data requirements received from 1 January 2024 will be progressed within 150 days. Applications that do not meet these requirements will be progressed within the statutory 210 days.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-06-20T14:25:47.907Zmore like thismore than 2023-06-20T14:25:47.907Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1643765
registered interest false more like this
date less than 2023-06-12more like thismore than 2023-06-12
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Licensing more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many products in the D150 submission category have been waiting for Medicines and Healthcare products Regulatory Agency approval for over 150 days; and how many of those products are specifically for women’s health. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 188921 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-06-21more like thismore than 2023-06-21
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) offers a 150-day assessment timeline for all high-quality marketing authorisation applications.</p><p>A total of 1,016 medicinal products have been waiting for MHRA marketing authorisation approval for more than 150 days. Of these, 36 are for women’s health.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN
189040 more like this
189041 more like this
question first answered
less than 2023-06-21T14:53:35.87Zmore like thismore than 2023-06-21T14:53:35.87Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1628587
registered interest false more like this
date less than 2023-05-17more like thismore than 2023-05-17
answering body
Department for Work and Pensions more like this
answering dept id 29 more like this
answering dept short name Work and Pensions more like this
answering dept sort name Work and Pensions more like this
hansard heading Disability more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Work and Pensions, with reference to the National Disability Strategy published 28 July 2021, if he will list which of those report's recommendations that have not been paused as a result of legal action has been (a) fully, (b) partially and (c) not been implemented by (i) action and (ii) Department responsible. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 185576 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-05-25more like thismore than 2023-05-25
answer text <p>In January 2022, the High Court declared the National Disability Strategy was unlawful because the UK Disability Survey, which informed it, was held to be a voluntary consultation that failed to comply with the legal requirements on public consultations.</p><p> </p><p>We are disappointed by, and strongly disagree with, the High Court’s finding, and the Secretary of State has been granted permission to appeal the Court's declaration.</p><p> </p><p>As the NDS was found to be unlawful, we are unable to provide you with the information in the format you have requested, as we do not centrally track commitments included in the NDS.</p><p> </p><p>We are fully committed to supporting disabled people in the UK through creating more opportunities, protecting their rights and ensuring they fully benefit from, and can contribute to, every aspect of our society. To support this, we will be providing details of the Government’s recent achievements to improve disabled people’s lives in the forthcoming Disability Action Plan consultation due for publication in the summer.</p><p> </p><p>Ahead of this, I will write providing a list of these achievements and will place a copy in the House Library.</p>
answering member constituency Corby more like this
answering member printed Tom Pursglove more like this
question first answered
less than 2023-05-25T11:16:43.807Zmore like thismore than 2023-05-25T11:16:43.807Z
answering member
4369
label Biography information for Tom Pursglove more like this
tabling member
4048
label Biography information for Caroline Nokes more like this
1623730
registered interest false more like this
date less than 2023-04-25more like thismore than 2023-04-25
answering body
Department for Business and Trade more like this
answering dept id 214 more like this
answering dept short name Business and Trade more like this
answering dept sort name Business and Trade more like this
hansard heading Equal Pay: Ethnic Groups more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business and Trade, when she plans to publish the Government’s response to its consultation on ethnicity pay reporting, which closed in January 2019. more like this
tabling member constituency Romsey and Southampton North remove filter
tabling member printed
Caroline Nokes more like this
uin 182547 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-05-02more like thismore than 2023-05-02
answer text <p>Last month we published voluntary guidance for employers on ethnicity pay reporting. The ethnicity pay reporting consultation response will be published shortly.</p> more like this
answering member constituency Thirsk and Malton more like this
answering member printed Kevin Hollinrake more like this
question first answered
less than 2023-05-02T13:48:54.35Zmore like thismore than 2023-05-02T13:48:54.35Z
answering member
4474
label Biography information for Kevin Hollinrake more like this
tabling member
4048
label Biography information for Caroline Nokes more like this